drugset / Trial / NCT02865824

Polypectomy in Patients Taking Dual Antiplatelet Agents

NCT02865824

Unknown 180 enrolled Incheon St.Mary's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Current guidelines recommend discontinuation of antiplatelets (i.e clopidogrel) for 7 days in patients taking DAT (dual antiplatelet therapy) before colonoscopy and polypectomy. The purpose of this study was to examine if a) discontinuation of these drugs reduces bleeding risks during polypectomy and if b) discontinuation of these drugs increases the occurence of thromboembolic events.

Timeline

Start
2016-01
Primary completion
2018-12
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule
Subject Prasugrel Small molecule
Subject Ticagrelor Small molecule

Indications